5.63
price down icon0.35%   -0.02
after-market After Hours: 5.63
loading

Why is Mannkind Corp (MNKD) Stock down?

03 Jul, 2023:

MannKind shares fell 2.21% after fire at a German manufacturing facility that may delay the planned initiation later this year of a phase 2/3 clinical study of MNKD-101. Clinical supplies of the treatment will be delayed an estimated three to six months, according to the filing MannKind said on Monday.

https://www.marketwatch.com/story/mannkind-shares-fall-after-fire-that-may-delay-clinical-trial-6b90acce?mod=pharmaceutical

$74.13
price down icon 1.09%
$20.11
price down icon 2.71%
$347.71
price down icon 1.71%
$4.69
price down icon 6.94%
biotechnology ONC
$223.50
price down icon 2.35%
$117.61
price down icon 1.94%
Cap:     |  Volume (24h):